Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
Intuitive Surgical
Stemline Therapeutics, Inc.
AstraZeneca
Perspectum
AstraZeneca
Incepta Pharmaceuticals Ltd
Hoffmann-La Roche
RemeGen Co., Ltd.
Novartis
TaiHao Medical Inc.
pfm medical gmbh
TaiHao Medical Inc.
BioNumerik Pharmaceuticals, Inc.
Myriad Genetic Laboratories, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Novartis
Seagen Inc.
Novartis
Concure Oncology-Breast Microseed Inc.
Medifocus, Inc.
Pfizer
Merck Sharp & Dohme LLC
Sysmex America, Inc.
Sysmex America, Inc.
Sysmex America, Inc.
Sysmex America, Inc.